BARKLEY FNP POST-TEST QUESTIONS AND ANSWERS ALREADY GRADED A+| 100% VERIFIED
SOLUTIONS………...
Core Domains:
Advanced Pathophysiology and Clinical Manifestations
Pharmacotherapy and Prescriptive Decision-Making
Comprehensive Health Assessment and Differential Diagnosis
Evidence-Based Clinical Guidelines and Protocols
Health Maintenance, Screening, and Patient Education
Ethical, Legal, and Professional Practice Standards
Chronic Disease Management and Continuity of Care
Healthcare Systems, Quality Improvement, and Population Health
Introduction:
This post-test assessment is designed to evaluate advanced clinical competence and readiness for independent
practice as a Family Nurse Practitioner. The examination measures the candidate's ability to synthesize complex
patient data, formulate accurate differential diagnoses, and develop evidence-based treatment plans across the
lifespan. The structure includes multiple-choice questions that assess foundational knowledge, regulatory
compliance, and ethical decision-making in clinical practice. This assessment emphasizes real-world application,
,challenging the test-taker to prioritize care, communicate effectively with patients and families, and navigate
healthcare systems to optimize patient outcomes.
SECTION ONE: QUESTIONS 1–100
1. A 58-year-old male with a 20-year history of type 2 diabetes mellitus presents for a routine follow-up. His
current medications include metformin 1000 mg twice daily and glipizide 10 mg daily. His most recent HbA1c
is 8.2%. He reports adherence to his medications but admits to a sedentary lifestyle. Which of the following
is the most appropriate next step in managing his glycemic control?
A. Add a DPP-4 inhibitor
B. Add a GLP-1 receptor agonist
C. Add basal insulin
D. Increase metformin to 2000 mg twice daily
🟢 B. Add a GLP-1 receptor agonist
🔴 RATIONALE: GLP-1 receptor agonists are preferred as add-on therapy to metformin when HbA1c is
significantly above goal, especially in patients with cardiovascular risk factors, as they provide both glycemic
control and weight loss benefits. Basal insulin is typically considered after failure of two or more oral agents.
,2. A 72-year-old female with a history of hypertension and osteoarthritis presents with a new onset of
bilateral hand pain, stiffness, and swelling. She reports morning stiffness lasting over one hour. Her
rheumatoid factor is positive and anti-CCP antibodies are elevated. Which of the following is the most
appropriate initial disease-modifying antirheumatic drug (DMARD) for this patient?
A. Hydroxychloroquine
B. Sulfasalazine
C. Methotrexate
D. Leflunomide
🟢 C. Methotrexate
🔴 RATIONALE: Methotrexate is the first-line DMARD for rheumatoid arthritis due to its efficacy, rapid onset,
and favorable risk-benefit profile. It is the anchor drug in most treatment protocols.
3. A 45-year-old female presents with a chief complaint of fatigue, weight gain, and cold intolerance. Her
TSH is 15 mIU/L. She is started on levothyroxine 50 mcg daily. What is the most appropriate time to reassess
her TSH level?
A. 2 weeks
B. 4 weeks
C. 6-8 weeks
D. 12 weeks
🟢 C. 6-8 weeks
🔴 RATIONALE: TSH levels should be reassessed 6-8 weeks after initiating or adjusting levothyroxine therapy, as
, this allows sufficient time for the medication to reach steady state and for the hypothalamic-pituitary-thyroid
axis to respond.
4. A 35-year-old male presents with a painful, swollen right testicle. He reports a fever and dysuria. On
examination, the testicle is tender and enlarged. Which of the following is the most likely diagnosis?
A. Testicular torsion
B. Epididymitis
C. Orchitis
D. Inguinal hernia
🟢 C. Orchitis
🔴 RATIONALE: Orchitis is inflammation of the testicle, often associated with fever, pain, and swelling. It may be
caused by viral (mumps) or bacterial infections. Epididymitis primarily affects the epididymis, whereas orchitis
involves the testicle itself.
5. A 66-year-old male with a history of coronary artery disease and heart failure (NYHA class III) presents
with worsening dyspnea and peripheral edema. His ejection fraction is 30%. He is on lisinopril, carvedilol,
and furosemide. Which of the following medications should be considered to reduce mortality in this
patient?
SOLUTIONS………...
Core Domains:
Advanced Pathophysiology and Clinical Manifestations
Pharmacotherapy and Prescriptive Decision-Making
Comprehensive Health Assessment and Differential Diagnosis
Evidence-Based Clinical Guidelines and Protocols
Health Maintenance, Screening, and Patient Education
Ethical, Legal, and Professional Practice Standards
Chronic Disease Management and Continuity of Care
Healthcare Systems, Quality Improvement, and Population Health
Introduction:
This post-test assessment is designed to evaluate advanced clinical competence and readiness for independent
practice as a Family Nurse Practitioner. The examination measures the candidate's ability to synthesize complex
patient data, formulate accurate differential diagnoses, and develop evidence-based treatment plans across the
lifespan. The structure includes multiple-choice questions that assess foundational knowledge, regulatory
compliance, and ethical decision-making in clinical practice. This assessment emphasizes real-world application,
,challenging the test-taker to prioritize care, communicate effectively with patients and families, and navigate
healthcare systems to optimize patient outcomes.
SECTION ONE: QUESTIONS 1–100
1. A 58-year-old male with a 20-year history of type 2 diabetes mellitus presents for a routine follow-up. His
current medications include metformin 1000 mg twice daily and glipizide 10 mg daily. His most recent HbA1c
is 8.2%. He reports adherence to his medications but admits to a sedentary lifestyle. Which of the following
is the most appropriate next step in managing his glycemic control?
A. Add a DPP-4 inhibitor
B. Add a GLP-1 receptor agonist
C. Add basal insulin
D. Increase metformin to 2000 mg twice daily
🟢 B. Add a GLP-1 receptor agonist
🔴 RATIONALE: GLP-1 receptor agonists are preferred as add-on therapy to metformin when HbA1c is
significantly above goal, especially in patients with cardiovascular risk factors, as they provide both glycemic
control and weight loss benefits. Basal insulin is typically considered after failure of two or more oral agents.
,2. A 72-year-old female with a history of hypertension and osteoarthritis presents with a new onset of
bilateral hand pain, stiffness, and swelling. She reports morning stiffness lasting over one hour. Her
rheumatoid factor is positive and anti-CCP antibodies are elevated. Which of the following is the most
appropriate initial disease-modifying antirheumatic drug (DMARD) for this patient?
A. Hydroxychloroquine
B. Sulfasalazine
C. Methotrexate
D. Leflunomide
🟢 C. Methotrexate
🔴 RATIONALE: Methotrexate is the first-line DMARD for rheumatoid arthritis due to its efficacy, rapid onset,
and favorable risk-benefit profile. It is the anchor drug in most treatment protocols.
3. A 45-year-old female presents with a chief complaint of fatigue, weight gain, and cold intolerance. Her
TSH is 15 mIU/L. She is started on levothyroxine 50 mcg daily. What is the most appropriate time to reassess
her TSH level?
A. 2 weeks
B. 4 weeks
C. 6-8 weeks
D. 12 weeks
🟢 C. 6-8 weeks
🔴 RATIONALE: TSH levels should be reassessed 6-8 weeks after initiating or adjusting levothyroxine therapy, as
, this allows sufficient time for the medication to reach steady state and for the hypothalamic-pituitary-thyroid
axis to respond.
4. A 35-year-old male presents with a painful, swollen right testicle. He reports a fever and dysuria. On
examination, the testicle is tender and enlarged. Which of the following is the most likely diagnosis?
A. Testicular torsion
B. Epididymitis
C. Orchitis
D. Inguinal hernia
🟢 C. Orchitis
🔴 RATIONALE: Orchitis is inflammation of the testicle, often associated with fever, pain, and swelling. It may be
caused by viral (mumps) or bacterial infections. Epididymitis primarily affects the epididymis, whereas orchitis
involves the testicle itself.
5. A 66-year-old male with a history of coronary artery disease and heart failure (NYHA class III) presents
with worsening dyspnea and peripheral edema. His ejection fraction is 30%. He is on lisinopril, carvedilol,
and furosemide. Which of the following medications should be considered to reduce mortality in this
patient?
